Specify a stock or a cryptocurrency in the search bar to get a summary
Pulse Biosciences Inc
6L8Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. Address: 3957 Point Eden Way, Hayward, CA, United States, 94545
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 6L8
Dividend Analytics 6L8
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 6L8
Stock Valuation 6L8
Financials 6L8
Results | 2019 | Dynamics |